v3.26.1
Offsetting Assets and Liabilities (Tables)
 3 Months Ended
Mar. 31, 2026
Offsetting [Abstract]  
Schedule of Offsetting Assets
The composition of offsetting derivative instruments, financial assets, and financial liabilities was as follows.
Gross amounts of recognized assets/liabilitiesGross amounts offset on the Condensed Consolidated Balance SheetNet amounts of assets/liabilities presented on the Condensed Consolidated Balance SheetGross amounts not offset on the Condensed Consolidated Balance Sheet
($ in millions)
Financial instruments
Collateral (a) (b) (c)
Net amount
March 31, 2026
Assets
Derivative assets$3 $— $3 $(1)$(2)$— 
Total assets
$3 $— $3 $(1)$(2)$— 
Liabilities
Derivative liabilities (d)$3 $— $3 $(1)$(1)$1 
Securities sold under agreements to repurchase (e)526 — 526 — (526)— 
Total liabilities$529 $— $529 $(1)$(527)$1 
December 31, 2025
Assets
Derivative assets$— $— $— $— $— $— 
Total assets
$— $— $— $— $— $— 
Liabilities
Derivative liabilities$4 $— $4 $— $(4)$— 
Securities sold under agreements to repurchase (e)545 — 545 — (545)— 
Total liabilities$549 $— $549 $— $(549)$— 
(a)Financial collateral received or pledged shown as a balance based on the sum of all net asset and liability positions between Ally and each individual derivative counterparty.
(b)Amounts disclosed are limited to the financial asset or liability balance and, accordingly, exclude excess collateral received or pledged and noncash collateral received. We do not record noncash collateral received on our Condensed Consolidated Balance Sheet unless certain conditions are met.
(c)Certain agreements grant us the right to sell or pledge the noncash assets we receive as collateral. We have not sold or pledged any of the noncash collateral received under these agreements.
(d)Includes derivative liabilities with no offsetting arrangements of $1 million as of March 31, 2026.
(e)For additional information on securities sold under agreements to repurchase, refer to Note 12.
Schedule of Offsetting Liabilities
The composition of offsetting derivative instruments, financial assets, and financial liabilities was as follows.
Gross amounts of recognized assets/liabilitiesGross amounts offset on the Condensed Consolidated Balance SheetNet amounts of assets/liabilities presented on the Condensed Consolidated Balance SheetGross amounts not offset on the Condensed Consolidated Balance Sheet
($ in millions)
Financial instruments
Collateral (a) (b) (c)
Net amount
March 31, 2026
Assets
Derivative assets$3 $— $3 $(1)$(2)$— 
Total assets
$3 $— $3 $(1)$(2)$— 
Liabilities
Derivative liabilities (d)$3 $— $3 $(1)$(1)$1 
Securities sold under agreements to repurchase (e)526 — 526 — (526)— 
Total liabilities$529 $— $529 $(1)$(527)$1 
December 31, 2025
Assets
Derivative assets$— $— $— $— $— $— 
Total assets
$— $— $— $— $— $— 
Liabilities
Derivative liabilities$4 $— $4 $— $(4)$— 
Securities sold under agreements to repurchase (e)545 — 545 — (545)— 
Total liabilities$549 $— $549 $— $(549)$— 
(a)Financial collateral received or pledged shown as a balance based on the sum of all net asset and liability positions between Ally and each individual derivative counterparty.
(b)Amounts disclosed are limited to the financial asset or liability balance and, accordingly, exclude excess collateral received or pledged and noncash collateral received. We do not record noncash collateral received on our Condensed Consolidated Balance Sheet unless certain conditions are met.
(c)Certain agreements grant us the right to sell or pledge the noncash assets we receive as collateral. We have not sold or pledged any of the noncash collateral received under these agreements.
(d)Includes derivative liabilities with no offsetting arrangements of $1 million as of March 31, 2026.
(e)For additional information on securities sold under agreements to repurchase, refer to Note 12.